Why Attend?
Pharma and Biotech patent law continues to an area of debate for innovators, generics, biologics and biosimilars. The differentiator for you will be how your company maximises its return on investment on patent rights and IP protection.
Our globally recognised event will provide you with the capability and confidence to successfully defend post-grant patent challenges and maximise your patent litigation strategy to ensure your products are protected in an ever increasingly competitive market.
If you are an Intellectual Property Attorney, Senior Counsel, or Director of IP, then this is the event for you.
Leading Topics to be Addressed at the Event Include:
Pharma and Biotech patent law continues to an area of debate for innovators, generics, biologics and biosimilars. The differentiator for you will be how your company maximises its return on investment on patent rights and IP protection.
Our globally recognised event will provide you with the capability and confidence to successfully defend post-grant patent challenges and maximise your patent litigation strategy to ensure your products are protected in an ever increasingly competitive market.
If you are an Intellectual Property Attorney, Senior Counsel, or Director of IP, then this is the event for you.
Leading Topics to be Addressed at the Event Include:
- Join our action-packed pre-event workshop day, with UPC, Medical Device and Antibody Patent Litigation sessions.
- Gain a transatlantic understanding of biologics patent litigation by understanding topics such as: biosimilar launches, section 112 and sufficiency of disclosure.
- Examine recent case law in Europe on preliminary injunctions and assess how the decisions affect your litigation strategy.
- Understand the impact of the SPC regulation changes and evaluate the uptake of the manufacturing waiver.
- A multi-session analysis of the changes that the UPC is bringing to the pharma and biotech patent litigation world, including: a mock trial, an industry take on the court and a regulatory fireside update.
- Gain all the latest insights on the doctrine of equivalents in Europe and the US.
- Join our interactive international roundtable sessions and gain the latest patent litigation updates on key global jurisdictions.
- Understand important industry comparisons between European second medical use and US skinny label litigation.
